Ikarian Capital, LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$3.0B
Holdings
238
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (238 positions)
| Stock | Value |
|---|---|
SPYSPDR S&P 500 ETF TR | $218.0M |
XBISPDR SER TR | $176.3M |
ARKKARK ETF TR | $131.9M |
BIIBBIOGEN INC | $112.1M |
IWMISHARES TR | $99.4M |
TLTISHARES TR | $94.8M |
MRNAMODERNA INC | $91.7M |
ARKGARK ETF TR | $76.0M |
NDQINVESCO QQQ TR | $63.8M |
ONCBEIGENE LTD | $59.5M |
HZNPHORIZON THERAPEUTICS PUB L | $58.2M |
XLISELECT SECTOR SPDR TR | $49.2M |
NVV1NOVAVAX INC | $48.7M |
MRTXEURMIRATI THERAPEUTICS INC | $43.9M |
VRTXVERTEX PHARMACEUTICALS INC | $43.0M |
SOXXISHARES TR | $42.4M |
CVACCUREVAC N V | $42.1M |
SRPTSAREPTA THERAPEUTICS INC | $41.4M |
XLFSELECT SECTOR SPDR TR | $37.8M |
IBBISHARES TR | $37.6M |
CCXIEURCHEMOCENTRYX INC | $36.5M |
SG7SAGE THERAPEUTICS INC | $33.3M |
CARAEURCARA THERAPEUTICS INC | $30.5M |
BEAMBEAM THERAPEUTICS INC | $28.8M |
GILDGILEAD SCIENCES INC | $28.7M |
EXASEXACT SCIENCES CORP | $27.0M |
—GW PHARMACEUTICALS PLC | $25.8M |
BHCBAUSCH HEALTH COS INC | $25.4M |
SMHVANECK VECTORS ETF TR | $24.4M |
LLYLILLY ELI & CO | $23.4M |
MCRB1EURSERES THERAPEUTICS INC | $23.3M |
GLPGGALAPAGOS NV | $23.2M |
TCE2CELLDEX THERAPEUTICS INC NEW | $22.7M |
TCONTRACON PHARMACEUTICALS INC | $22.4M |
MGNXMACROGENICS INC | $22.3M |
ITCIEURINTRA CELLULAR THERAPIES INC | $20.9M |
1K0IGM BIOSCIENCES INC | $19.2M |
—ZOGENIX INC | $19.0M |
INCYINCYTE CORP | $18.1M |
UTHUNITED THERAPEUTICS CORP DEL | $17.6M |
AZNASTRAZENECA PLC | $17.4M |
RLMDRELMADA THERAPEUTICS INC | $17.2M |
ARGXARGENX SE | $16.9M |
CMRXEURCHIMERIX INC | $16.8M |
JAZZJAZZ PHARMACEUTICALS PLC | $16.4M |
BABOEING CO | $15.3M |
ACADACADIA PHARMACEUTICALS INC | $15.1M |
—CURIS INC | $14.9M |
TWSTTWIST BIOSCIENCE CORP | $14.9M |
ASNDASCENDIS PHARMA A/S | $14.5M |
XENEXENON PHARMACEUTICALS INC | $14.2M |
ALLKGUSDALLAKOS INC | $12.9M |
VIRVIR BIOTECHNOLOGY INC | $12.8M |
XLUSELECT SECTOR SPDR TR | $12.8M |
TXG10X GENOMICS INC | $12.7M |
GOSSGOSSAMER BIO INC | $12.5M |
NBPI MAB | $12.1M |
2L9BLUEPRINT MEDICINES CORP | $11.7M |
OCULOCULAR THERAPEUTIX INC | $11.2M |
PRTAPROTHENA CORP PLC | $11.0M |
ASNSUSDX4 PHARMACEUTICALS INC | $10.6M |
MISTMILESTONE PHARMACEUTICALS IN | $10.6M |
ARNAEURARENA PHARMACEUTICALS INC | $10.6M |
RETAEURREATA PHARMACEUTICALS INC | $10.5M |
FGENEURFIBROGEN INC | $10.4M |
TARAPROTARA THERAPEUTICS INC | $10.2M |
PCVXVAXCYTE INC | $9.9M |
IMVTIMMUNOVANT INC | $9.7M |
FATEFATE THERAPEUTICS INC | $9.3M |
—GEMINI THERAPEUTICS INC | $9.3M |
LYRALYRA THERAPEUTICS INC | $9.0M |
SCPHSCPHARMACEUTICALS INC | $8.7M |
—VINCERX PHARMA INC | $8.5M |
CMPSCOMPASS PATHWAYS PLC | $8.3M |
EPIEURESSA PHARMA INC | $7.7M |
—SIERRA ONCOLOGY INC | $7.7M |
NVTA1EURINVITAE CORP | $7.6M |
STROSUTRO BIOPHARMA INC | $7.6M |
KALVKALVISTA PHARMACEUTICALS INC | $7.6M |
SDGRSCHRODINGER INC | $7.6M |
ADCTADC THERAPEUTICS SA | $7.3M |
AUTLAUTOLUS THERAPEUTICS PLC | $7.2M |
CRSPCRISPR THERAPEUTICS AG | $6.9M |
RCUSARCUS BIOSCIENCES INC | $6.9M |
RVMDREVOLUTION MEDICINES INC | $6.9M |
ARDXARDELYX INC | $6.8M |
BTAIEURBIOXCEL THERAPEUTICS INC | $6.7M |
VSTMVERASTEM INC | $6.7M |
AGIOAGIOS PHARMACEUTICALS INC | $6.5M |
MSOSADVISORSHARES TR | $6.4M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $6.3M |
LRMRLARIMAR THERAPEUTICS INC | $6.2M |
VTGNUSDVISTAGEN THERAPEUTICS INC | $6.1M |
—HARPOON THERAPEUTICS INC | $5.6M |
STTKSHATTUCK LABS INC | $5.6M |
RAPTEURRAPT THERAPEUTICS INC | $5.5M |
ANVSANNOVIS BIO INC | $5.4M |
—SYNLOGIC INC | $5.3M |
—LIFESCI ACQUISITION II CORP | $5.2M |
ALECALECTOR INC | $5.2M |
Page 1 of 3Next